...
...
Next Story

Coffee may help prevent breast cancer recurrence

Updated on: Apr 26, 2013, 18:02:52 IST
HT Image
HT Image
Advertisement

Drinking two or more cups of coffee daily could decrease the risk of breast cancer recurring in patients taking the widely used drug Tamoxifen. In the study, patients who took the pill, along with two or more...

Drinking two or more cups of coffee daily could decrease the risk of breast cancer recurring in patients taking the widely used drug Tamoxifen, a study at Lund University in Sweden has suggested.

In the study, patients who took the pill, along with two or more cups of coffee daily, reported less than half the rate of cancer recurrence, compared with their non-coffee drinking, Tamoxifen-taking counterparts.

The team followed over 600 breast cancer patients from southern Sweden for an average of five years. Approximately 300 took Tamoxifen. The drug, a common hormone therapy after breast cancer surgery, reduces the risk of new tumours by blocking oestrogen receptors.

How coffee interacts with the treatment, however, isn’t immediately known.

“One theory we are working with is that coffee ‘activates’ Tamoxifen and makes it more efficient”, said Maria Simonsson, doctoral student in Oncology at Lund University.

The Lund University researchers have previously linked coffee consumption to a decreased risk of developing certain types of breast cancer.

 
Catch every big hit, every wicket with Crick-it, a one stop destination for Live Scores, Match Stats, Quizzes, Polls & much more. Explore now!.

Catch your daily dose of Fashion, Taylor Swift, Health, Festivals, Travel, Relationship, Recipe and all the other Latest Lifestyle News on Hindustan Times Website and APPs.
Catch every big hit, every wicket with Crick-it, a one stop destination for Live Scores, Match Stats, Quizzes, Polls & much more. Explore now!.

Catch your daily dose of Fashion, Taylor Swift, Health, Festivals, Travel, Relationship, Recipe and all the other Latest Lifestyle News on Hindustan Times Website and APPs.
SHARE THIS ARTICLE ON